Document Classification

Section Type: RESULTS

Text: At a median follow-up of 8 years, univariate analysis adjusted for treatment showed positive ER mRNA status to be of borderline significance for reduced risk of relapse (HR = 0. 65, 95 % CI 0. 41-1. 01, P = 0. 055) and death (HR = 0. 62, 95 % CI 0. 36-1. 05, P = 0. 077), while positive MAP-Tau mRNA status was significantly associated with reduced risk of relapse (HR = 0. 50, 95 % CI 0. 32-0. 78, P = 0. 002) and death (HR = 0. 49, 95 % CI 0. 29-0. 83, P = 0. 008).